Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight ...

Patient-centered care in MM involves aligning treatment with evolving quality-of-life priorities, especially during remission.

Patients share their unexpected journeys with multiple myeloma, revealing challenges and resilience in the face of a cancer ...

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have uncovered biological differences in how multiple myeloma develops and progresses in men and in women. The ...

MM survival rates have improved with the introduction of novel agents. Treatment of MM within the first year is associated with improved survival. New research has concluded that, despite more ...

Maintenance therapy is given after initial treatment for multiple myeloma. It aims to control your cancer and prevent progression. The type of maintenance therapy you receive depends on whether your ...

DURHAM, N.C. -- Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer cells, but also increases the effectiveness of ...

Lynozyfic (linvoseltamab-gcpt) is a prescription injection medicine for people with a type of blood cancer called multiple myeloma, whose cancer has come back (relapsed) or worsened (refractory) after ...

Are an adult with relapsed or refractory multiple myeloma Have tried at least four previous lines of treatments for multiple myeloma, including: Immune system modulators (help boost the immune system ...